Fidaxomicin: A novel agent for the treatment of Clostridium difficile infection

BACKGROUND: Due to the limitations of existing treatment options for Clostridium difficile infection (CDI), new therapies are needed. OBJECTIVE: To review the available data on fidaxomicin regarding chemistry, mechanisms of action and resistance, in vitro activity, pharmacokinetic and pharmacodynami...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhanel, George G, Walkty, Andrew J, Karlowsky, James A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pulsus Group Inc 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4692299/
https://www.ncbi.nlm.nih.gov/pubmed/26744587

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4692299/
https://www.ncbi.nlm.nih.gov/pubmed/26744587

Ejemplares similares